The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
GeneDx Holdings is facing a securities class action lawsuit following a 49% single-day crash in its stock price in May 2026. The decline is linked to a 94% write-off of assets associated with the acquisition of Fabric Genomics and poor Q1 2026 financial results. The lawsuit follows a significant drop in share value, which fell by $33.42 during the period in question.